Citius Pharmaceuticals annual operating margin
2017
2018
2019
2020
2021
2022
Citius Pharmaceuticals Operating Margin Growth & History (CTXR)
Citius Pharmaceuticals's operating margin was −37,017.83% for fiscal 2022.
View full Citius Pharmaceuticals company overviewCitius Pharmaceuticals annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2022 | 2022-09-30 | −37,017.83% | −10871.28 pp |
| 2021 | 2021-09-30 | −26,146.55% | −6468.01 pp |
| 2020 | 2020-09-30 | −19,678.54% | −2347.03 pp |
| 2019 | 2019-09-30 | −17,331.51% | +1054.01 pp |
| 2018 | 2018-09-30 | −18,385.52% | +1587.10 pp |
| 2017 | 2017-09-30 | −19,972.62% | — |
Citius Pharmaceuticals quarterly operating margin
Q1.26
Q2.26
Q3.26
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q3 2026 | 2026-06-30 | −785.39% | — |
| Q2 2026 | 2026-03-31 | −1,930.96% | — |
| Q1 2026 | 2025-12-31 | −228.68% | — |
Citius Pharmaceuticals operating margin trends
Over the last five reported fiscal years, Citius Pharmaceuticals's operating margin decreased from −19,972.62% to −37,017.83%, a change of −17045.21 percentage points. The latest reported quarter, Q3 2026, shows −785.39%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Citius Pharmaceuticals filings at SEC.gov ↗